September 19, 2020

The Niche

Knoepfler lab stem cell blog

Month: July 2016

1 min read

Need a fix of some stem cell good news? I do. It has been a bumpy 2016 so far for the stem cell field and many challenges have popped up. So today at lunch and needing at least a short break from grant writing,  I went looking for stem cell good news including interesting studies, promising trials, and frankly things that just sound unusual or even weird. I’ve listed these below. Have a good weekend…you know what I’ll be doing: working on my grant. If …Read More

3 min read

The journal Nature published an excellent editorial earlier this week on stem cell oversight and stem cell clinics. The piece, entitled ” FDA should stand firm on stem-cell treatments. US regulators must regain the upper hand in the approval system” struck just the right balance. It correctly supported the FDA’s data-centered approach to stem cell oversight and indicated that this regulatory system is not too harsh. At the same time, the editorial also rightly asserted that the FDA cannot simply stick entirely to the status quo …Read More

3 min read

The REGROW Act is a bill that seeks to lessen the regulatory burden to accelerate getting stem cells to patients more quickly, but it over-reaches so much that it would almost certainly do harm to patients and maybe to the stem cell field as a whole. The REGROW Act, which is sponsored by Senator Mark Kirk of Illinois, has had several incarnations, but the latest new one reflects some big changes so I’m going to call it REGROW 2.0. A source provided me with a …Read More

2 min read

It’s an exciting time to be a stem cell scientist and I feel fortunate to be doing research on stem cells today what with all the developments recently and real promise for clinical impact in coming decades. There’s also unfortunately a ton of hype out there including in academia, biotech, and the stem cell clinic arena. That’s something we all need to be aware of and avoid as much as possible. Hype and hope are only different by one letter (y versus o), but …Read More